Literature DB >> 11877740

Preferred conformations of RGDX tetrapeptides to inhibit the binding of fibrinogen to platelets.

Hae Sook Park1, Choonmi Kim, Young Kee Kang.   

Abstract

The conformational study on Arg-Gly-Asp (RGD)-containing tetrapeptides in the unhydrated and hydrated states has been carried out using the force field ECEPP/3 and the hydration shell model. The tetrapeptides studied here are H-RGDX-OH (X = Trp, Tyr, Phe, Leu, Val, Cys, Gln, and Ser), which show the inhibitory activity for binding of fibrinogen to platelets in the order of RGDW approximately equal to RGDY approximately equal to RGDF approximately equal to RGDL > RGDV > or = RGDC > or = RGDQ > or = RGDS. The backbone conformations with two C(7) backbone-to-backbone hydrogen bonds between Asp and Arg residues and between Xaa and Gly residues are in common most probable for the RGD sequence of RGDX tetrapeptides in the hydrated state. The dominant beta-turns for RGDX are found to be the types V' and IV at Gly-Asp and Asp-Xaa sequences, respectively, which are quite similar to the types II' and I (or II), respectively. However, it cannot be ruled out that the extended conformations are also remarkably feasible for RGDX tetrapeptides in water by peering the distributions of backbone conformations. These calculated results are consistent with the experimental results on RGD-containing proteins and conformationally constrained RGD-containing peptides. The reason why the RGDX becomes more potent as the side chain of the X residue is more hydrophobic may be ascribed to that the more hydrophobic is the residue X, the more populated are beta-turn structures for the Gly-Asp sequence. The hydrophobic side chain of X residue exposed to water is likely to interact with the hydrophobic region of receptor easily. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877740     DOI: 10.1002/bip.10067

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  4 in total

1.  Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1.

Authors:  Johannes F Van Agthoven; Hengameh Shams; Frank V Cochran; José L Alonso; James R Kintzing; Kiavash Garakani; Brian D Adair; Jian-Ping Xiong; Mohammad R K Mofrad; Jennifer R Cochran; M Amin Arnaout
Journal:  Structure       Date:  2019-07-25       Impact factor: 5.006

2.  RGD Peptide-Pegylated PLLA Nanoparticles Containing Epirubicin Hydrochloride Exhibit Receptor-Dependent Tumor Trafficking In Vitro and In Vivo.

Authors:  Ping Huang; Jun Wu; Ximeng Li; Xiaozheng Liu; Yinghuan Li; Guohui Cui
Journal:  Pharm Res       Date:  2015-01-16       Impact factor: 4.200

3.  Synthesis and self-assembly of RGD-functionalized PEO-PB amphiphiles.

Authors:  John A Zupancich; Frank S Bates; Marc A Hillmyer
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

4.  Arginine-glycine-aspartic acid-polyethylene glycol-polyamidoamine dendrimer conjugate improves liver-cell aggregation and function in 3-D spheroid culture.

Authors:  Zhanfei Chen; Fen Lian; Xiaoqian Wang; Yanling Chen; Nanhong Tang
Journal:  Int J Nanomedicine       Date:  2016-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.